bims-tremylTherapy resistance biology in myeloid leukemia
This report is maintained by Paolo Gallipoli, Barts Cancer Institute, Queen Mary University of London. It brings out roughly 30 papers per issue.
0000‒00‒00
 Sign up
2026–10–04
2026–09–27
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2026–09–20
2026–09–13
2026–09–06
2026–08–30
2026–08–23
2026–08–16
2026–08–09
2026–08–02
2026–07–26
2026–07–19
2026–07–12
2026–07–05
2026–06–28
2026–06–21
2026–06–14
2026–06–07
2026–05–31
2026–05–24
2026–05–17
2026–05–10
2026–05–03
2026–04–26
2026–04–19
2026–04–12
2026–04–05
2026–03–29
2026–03–22
2026–03–15
2026–03–08
2026–03–01
2026–02–22
2026–02–15
2026–02–08
2026–02–01
2026–01–25
2026–01–18
2026–01–11
2026–01–04
2025–12–28
2025–12–21
2025–12–14
2025–12–07
2025–11–30
2025–11–23
2025–11–16
2025–11–09
2025–11–02
2025–10–26
2025–10–19
2025–10–12
2025–10–05
2025–09–28
2025–09–21
2025–09–14
2025–09–07
2025–08–31
2025–08–24
2025–08–17
2025–08–10
2025–08–03
2025–07–27
2025–07–20
2025–07–13
2025–07–06
2025–06–29
2025–06–22
2025–06–15
2025–06–08
2025–06–01
2025–05–25
2025–05–18
2025–05–11
2025–05–04
2025–04–27
2025–04–20
2025–04–13
2025–04–06
2025–03–30
2025–03–23
2025–03–16
2025–03–09
2025–03–02
2025–02–23
2025–02–16
2025–02–09
2025–02–02
2025–01–26
2025–01–19
2025–01–12
2025–01–05
2024–12–29
2024–12–22
2024–12–15
2024–12–08
2024–12–01
2024–11–24
2024–11–17
2024–11–10
2024–11–03
2024–10–27
2024–10–20
2024–10–13
2024–10–06
2024–09–29
2024–09–22
2024–09–15
2024–09–08
2024–09–01
2024–08–25
2024–08–18
2024–08–11
2024–08–04
2024–07–28
2024–07–21
2024–07–14
2024–07–07
2024–06–30
2024–06–23
2024–06–16
2024–06–09
2024–06–02
2024–05–26
2024–05–19
2024–05–12
2024–05–05
2024–04–28
2024–04–21
2024–04–14
2024–04–07
2024–03–31
2024–03–24
2024–03–17
2024–03–10
2024–03–03
2024–02–25
2024–02–18
2024–02–11
2024–02–04
2024–01–28
2024–01–21
2024–01–14
2024–01–07
2023–12–31
2023–12–24
2023–12–17
2023–12–10
2023–12–03
2023–11–26
2023–11–19
2023–11–12
2023–11–05
2023–10–29
2023–10–22
2023–10–15
2023–10–08
2023–10–01
2023–09–24
2023–09–17
2023–09–10
2023–09–03
2023–08–27
2023–08–20
2023–08–13
2023–08–06
2023–07–30
2023–07–23
2023–07–16
2023–07–09
2023–07–02
2023–06–25
2023–06–18
2023–06–11
2023–06–04
2023–05–28
2023–05–21
2023–05–14
2023–05–07
2023–04–30
2023–04–23
2023–04–16
2023–04–09
2023–04–02
2023–03–26
2023–03–19
2023–03–12
2023–03–05
2023–02–26
2023–02–19
2023–02–12
2023–02–05
2023–01–29
2023–01–22
2023–01–15
2023–01–08
2023–01–01
2022–12–25
2022–12–18
2022–12–11
2022–12–04
2022–11–27
2022–11–20
2022–11–13
2022–11–06
2022–10–30
2022–10–23
2022–10–16
2022–10–09
2022–10–02
2022–09–25
2022–09–18
2022–09–11
2022–09–04
2022–08–28
2022–08–21
2022–08–14
2022–08–07
2022–07–31
2022–07–24
2022–07–17
2022–07–10
2022–07–03
2022–06–26
2022–06–19
2022–06–12
2022–06–05
2022–05–29
2022–05–22
2022–05–15
2022–05–08
2022–05–01
2022–04–24
2022–04–17
2022–04–10
2022–04–03
2022–03–27
2022–03–20
2022–03–13
2022–03–06
2022–02–27
2022–02–20
2022–02–13
2022–02–06
2022–01–30
2022–01–23
2022–01–16
2022–01–09
2022–01–02
2021–12–26
2021–12–19
2021–12–12
2021–12–05
2021–11–28
2021–11–21
2021–11–14
2021–11–07
2021–10–31
2021–10–24
2021–10–17
2021–10–10
2021–10–03
2021–09–26
2021–09–19
2021–09–12
2021–09–05
2021–08–29
2021–08–22
2021–08–15
2021–08–08
2021–08–01
2021–07–25
2021–07–18
2021–07–11
2021–07–04
2021–06–27
2021–06–20
2021–06–13
2021–06–06
2021–05–30
2021–05–23
2021–05–16
2021–05–09
2021–05–02
2021–04–25
2021–04–18
2021–04–11
2021–04–04
2021–03–28
2021–03–21
2021–03–14
2021–03–07
2021–02–28
2021–02–21
2021–02–14
2021–02–07
2021–01–31
2021–01–24
2021–01–17
2021–01–10
2021–01–03
2020–12–27
2020–12–20
2020–12–13
2020–12–06
2020–11–29
2020–11–22
2020–11–15
2020–11–08
2020–11–01
2020–10–25
2020–10–18
2020–10–11
2020–10–04
2020–09–27
2020–09–20
2020–09–13
2020–09–06
2020–08–30
2020–08–23
2020–08–16
2020–08–09
2020–08–02
2020–07–26
2020–07–19
2020–07–12
2020–07–05
2020–06–28
2020–06–21
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-scepro“Stem cell proteostasis”, ∼ 18 p.p.i. ∼ 18 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-hemali“Hematologic malignancies”, ∼ 22 p.p.i. ∼ 22 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-medica“Metabolism and diet in cancer”, ∼ 21 p.p.i. ∼ 21 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-mibica“Mitochondrial bioenergetics in cancer”, ∼ 24 p.p.i. ∼ 24 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-mithem“Mitochondria in Hematopoiesis”, ∼ 3 p.p.i. ∼ 3 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-camemi“Mitochondrial metabolism in cancer”, ∼ 48 p.p.i. ∼ 48 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-ginsta“Genome instability”, ∼ 32 p.p.i. ∼ 32 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2026‒10‒04 at 6:54.